Taika Capital LP Purchases Shares of 3,798 Encompass Health Co. (NYSE:EHC)

Taika Capital LP purchased a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 3,798 shares of the company's stock, valued at approximately $351,000.

A number of other hedge funds also recently modified their holdings of the business. AlphaQuest LLC grew its holdings in shares of Encompass Health by 216.5% during the fourth quarter. AlphaQuest LLC now owns 28,700 shares of the company's stock worth $2,650,000 after buying an additional 19,633 shares in the last quarter. Prescott Group Capital Management L.L.C. grew its holdings in shares of Encompass Health by 43.6% during the fourth quarter. Prescott Group Capital Management L.L.C. now owns 19,753 shares of the company's stock worth $1,824,000 after buying an additional 6,000 shares in the last quarter. Jackson Creek Investment Advisors LLC grew its holdings in shares of Encompass Health by 4.2% during the fourth quarter. Jackson Creek Investment Advisors LLC now owns 11,987 shares of the company's stock worth $1,107,000 after buying an additional 484 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of Encompass Health during the fourth quarter worth about $77,944,000. Finally, Arizona State Retirement System grew its holdings in shares of Encompass Health by 0.7% during the fourth quarter. Arizona State Retirement System now owns 29,204 shares of the company's stock worth $2,697,000 after buying an additional 212 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.10% of the company's stock.

Remove Ads

Encompass Health Stock Performance

NYSE:EHC traded down $0.71 during mid-day trading on Thursday, hitting $93.57. 836,587 shares of the stock were exchanged, compared to its average volume of 637,145. The stock has a market capitalization of $9.42 billion, a price-to-earnings ratio of 20.98, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. The firm's 50-day simple moving average is $97.22 and its 200 day simple moving average is $96.88. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. Encompass Health Co. has a fifty-two week low of $74.27 and a fifty-two week high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, equities analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.73%. Encompass Health's dividend payout ratio is presently 15.25%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Royal Bank of Canada restated an "outperform" rating and issued a $110.00 price target on shares of Encompass Health in a research note on Tuesday, February 11th. KeyCorp raised their price target on Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a research note on Saturday, February 15th. William Blair restated an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, Barclays raised their price target on Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, February 7th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, Encompass Health currently has an average rating of "Buy" and an average target price of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.